Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels

Howard Strickler, C. Escoffery, C. Rattray, D. Fuchs, H. Wachter, A. Manns, M. H. Schiffman, B. Cranston, B. Hanchard, W. A. Blattner

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Neopterin, a marker of cellular immune activation, was elevated in patients who had cervical cancer in previous studies. To examine neopterin in the presence of precursors to cervical cancer (i.e., cervical intraepithelial neoplasia) we measured serum levels in 185 colposcopy patients in Jamaica, a country with high cervical cancer incidence, and in 72 age-matched Jamaican women selected from a large population-based sample. We also measured serum levels of β-2-microglobulin, another commonly used marker of immune activation. Neopterin and β-2-microglobulin levels were not elevated in colposcopy patients; neither were they related to severity of cervical neoplasia. In multivariable analysis, neither adjustments for detection of cervical human papillomavirus DNA by PCR nor detection of antibodies to human T-cell lymphotropic virus type I (a retrovirus endemic to Jamaica) altered our findings. The absence of a serologically detectable increase in cellular immune activation linked to cervical intraepithelial neoplasia suggests that the immunological response to cervical intraepithelial neoplasia does not involve substantial systemic cellular immune activation.

Original languageEnglish (US)
Pages (from-to)295-298
Number of pages4
JournalCancer Epidemiology Biomarkers and Prevention
Volume4
Issue number3
StatePublished - 1995
Externally publishedYes

Fingerprint

Neopterin
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Jamaica
Colposcopy
Biomarkers
Serum
Retroviridae
Viruses
T-Lymphocytes
Polymerase Chain Reaction
Antibodies
DNA
Incidence
Population
Neoplasms

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Strickler, H., Escoffery, C., Rattray, C., Fuchs, D., Wachter, H., Manns, A., ... Blattner, W. A. (1995). Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels. Cancer Epidemiology Biomarkers and Prevention, 4(3), 295-298.

Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels. / Strickler, Howard; Escoffery, C.; Rattray, C.; Fuchs, D.; Wachter, H.; Manns, A.; Schiffman, M. H.; Cranston, B.; Hanchard, B.; Blattner, W. A.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 4, No. 3, 1995, p. 295-298.

Research output: Contribution to journalArticle

Strickler, H, Escoffery, C, Rattray, C, Fuchs, D, Wachter, H, Manns, A, Schiffman, MH, Cranston, B, Hanchard, B & Blattner, WA 1995, 'Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels', Cancer Epidemiology Biomarkers and Prevention, vol. 4, no. 3, pp. 295-298.
Strickler, Howard ; Escoffery, C. ; Rattray, C. ; Fuchs, D. ; Wachter, H. ; Manns, A. ; Schiffman, M. H. ; Cranston, B. ; Hanchard, B. ; Blattner, W. A. / Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels. In: Cancer Epidemiology Biomarkers and Prevention. 1995 ; Vol. 4, No. 3. pp. 295-298.
@article{2d8165ac7db84924bfb12091fd5631c6,
title = "Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels",
abstract = "Neopterin, a marker of cellular immune activation, was elevated in patients who had cervical cancer in previous studies. To examine neopterin in the presence of precursors to cervical cancer (i.e., cervical intraepithelial neoplasia) we measured serum levels in 185 colposcopy patients in Jamaica, a country with high cervical cancer incidence, and in 72 age-matched Jamaican women selected from a large population-based sample. We also measured serum levels of β-2-microglobulin, another commonly used marker of immune activation. Neopterin and β-2-microglobulin levels were not elevated in colposcopy patients; neither were they related to severity of cervical neoplasia. In multivariable analysis, neither adjustments for detection of cervical human papillomavirus DNA by PCR nor detection of antibodies to human T-cell lymphotropic virus type I (a retrovirus endemic to Jamaica) altered our findings. The absence of a serologically detectable increase in cellular immune activation linked to cervical intraepithelial neoplasia suggests that the immunological response to cervical intraepithelial neoplasia does not involve substantial systemic cellular immune activation.",
author = "Howard Strickler and C. Escoffery and C. Rattray and D. Fuchs and H. Wachter and A. Manns and Schiffman, {M. H.} and B. Cranston and B. Hanchard and Blattner, {W. A.}",
year = "1995",
language = "English (US)",
volume = "4",
pages = "295--298",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels

AU - Strickler, Howard

AU - Escoffery, C.

AU - Rattray, C.

AU - Fuchs, D.

AU - Wachter, H.

AU - Manns, A.

AU - Schiffman, M. H.

AU - Cranston, B.

AU - Hanchard, B.

AU - Blattner, W. A.

PY - 1995

Y1 - 1995

N2 - Neopterin, a marker of cellular immune activation, was elevated in patients who had cervical cancer in previous studies. To examine neopterin in the presence of precursors to cervical cancer (i.e., cervical intraepithelial neoplasia) we measured serum levels in 185 colposcopy patients in Jamaica, a country with high cervical cancer incidence, and in 72 age-matched Jamaican women selected from a large population-based sample. We also measured serum levels of β-2-microglobulin, another commonly used marker of immune activation. Neopterin and β-2-microglobulin levels were not elevated in colposcopy patients; neither were they related to severity of cervical neoplasia. In multivariable analysis, neither adjustments for detection of cervical human papillomavirus DNA by PCR nor detection of antibodies to human T-cell lymphotropic virus type I (a retrovirus endemic to Jamaica) altered our findings. The absence of a serologically detectable increase in cellular immune activation linked to cervical intraepithelial neoplasia suggests that the immunological response to cervical intraepithelial neoplasia does not involve substantial systemic cellular immune activation.

AB - Neopterin, a marker of cellular immune activation, was elevated in patients who had cervical cancer in previous studies. To examine neopterin in the presence of precursors to cervical cancer (i.e., cervical intraepithelial neoplasia) we measured serum levels in 185 colposcopy patients in Jamaica, a country with high cervical cancer incidence, and in 72 age-matched Jamaican women selected from a large population-based sample. We also measured serum levels of β-2-microglobulin, another commonly used marker of immune activation. Neopterin and β-2-microglobulin levels were not elevated in colposcopy patients; neither were they related to severity of cervical neoplasia. In multivariable analysis, neither adjustments for detection of cervical human papillomavirus DNA by PCR nor detection of antibodies to human T-cell lymphotropic virus type I (a retrovirus endemic to Jamaica) altered our findings. The absence of a serologically detectable increase in cellular immune activation linked to cervical intraepithelial neoplasia suggests that the immunological response to cervical intraepithelial neoplasia does not involve substantial systemic cellular immune activation.

UR - http://www.scopus.com/inward/record.url?scp=0028952585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028952585&partnerID=8YFLogxK

M3 - Article

C2 - 7606206

AN - SCOPUS:0028952585

VL - 4

SP - 295

EP - 298

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 3

ER -